Today Analogic Corporation (ALOG) Stock Rises

December 7, 2017 - By Vivian Currie

Investors sentiment decreased to 1.44 in Q2 2017. Its down 0.27, from 1.71 in 2017Q1. It dived, as 20 investors sold Analogic Corporation shares while 43 reduced holdings. 27 funds opened positions while 64 raised stakes. 12.26 million shares or 0.45% less from 12.31 million shares in 2017Q1 were reported.
516,299 were accumulated by Price T Rowe Associate Md. Advisory Research Inc has invested 0.63% in Analogic Corporation (NASDAQ:ALOG). Piermont Capital Mngmt owns 0.2% invested in Analogic Corporation (NASDAQ:ALOG) for 9,850 shares. Fny Managed Accounts accumulated 208 shares. 320,634 were accumulated by Ameriprise Inc. Ngam Advisors L P reported 62,795 shares stake. Thrivent Financial For Lutherans holds 0% or 7,530 shares in its portfolio. The United Kingdom-based Barclays Plc has invested 0% in Analogic Corporation (NASDAQ:ALOG). Axa has invested 0.01% in Analogic Corporation (NASDAQ:ALOG). Nationwide Fund reported 21,735 shares stake. Connor Clark & Lunn Inv Mngmt Limited accumulated 9,625 shares or 0% of the stock. Credit Suisse Ag holds 0% of its portfolio in Analogic Corporation (NASDAQ:ALOG) for 7,902 shares. Riverhead Cap Management Ltd Limited Liability Company holds 1,332 shares. Zurcher Kantonalbank (Zurich Cantonalbank) owns 0% invested in Analogic Corporation (NASDAQ:ALOG) for 509 shares. Moreover, Qs Investors Ltd has 0.02% invested in Analogic Corporation (NASDAQ:ALOG) for 27,777 shares.

Since June 15, 2017, it had 0 buys, and 1 sale for $12,204 activity.

The stock of Analogic Corporation (NASDAQ:ALOG) is a huge mover today! The stock increased 7.81% or $6.3 during the last trading session, reaching $86.95. About 270,902 shares traded or 232.57% up from the average. Analogic Corporation (NASDAQ:ALOG) has declined 8.54% since December 7, 2016 and is downtrending. It has underperformed by 25.24% the S&P500.
The move comes after 7 months positive chart setup for the $1.09 billion company. It was reported on Dec, 7 by Barchart.com. We have $92.17 PT which if reached, will make NASDAQ:ALOG worth $65.16M more.

Analogic Corporation (NASDAQ:ALOG) Ratings Coverage

Among 4 analysts covering Analogic Company (NASDAQ:ALOG), 1 have Buy rating, 0 Sell and 3 Hold. Therefore 25% are positive. Analogic Company had 6 analyst reports since November 23, 2015 according to SRatingsIntel. The stock has “Neutral” rating by Sidoti on Thursday, March 24. Jefferies initiated the stock with “Hold” rating in Wednesday, August 9 report. Jefferies maintained Analogic Corporation (NASDAQ:ALOG) rating on Wednesday, September 20. Jefferies has “Hold” rating and $75.0 target. The rating was maintained by Brean Capital with “Buy” on Thursday, September 22. Benchmark downgraded the shares of ALOG in report on Wednesday, December 7 to “Hold” rating.

More notable recent Analogic Corporation (NASDAQ:ALOG) news were published by: Globenewswire.com which released: “Analogic’s CT Checkpoint Screening Solution, ConneCT, Achieves US TSA …” on September 12, 2017, also Streetinsider.com with their article: “Analogic Corporation (ALOG) PT Raised to $80 at Jefferies Following 1Q” published on December 07, 2017, Globenewswire.com published: “Analogic Announces Results for the Fourth Quarter and Fiscal Year Ended July …” on September 19, 2017. More interesting news about Analogic Corporation (NASDAQ:ALOG) were released by: Globenewswire.com and their article: “Analogic Appoints Joseph Whitters to Board of Directors” published on October 13, 2017 as well as Globenewswire.com‘s news article titled: “Analogic Celebrates 50 Years of Imaging Innovation at RSNA 2017” with publication date: November 27, 2017.

Analogic Corporation designs, manufactures, and sells medical imaging systems, ultrasound and security systems, and subsystems to original equipment manufacturers and end users primarily for the medical and airport security markets worldwide. The company has market cap of $1.09 billion. It operates in three divisions: Medical Imaging, Ultrasound, and Security and Detection. It currently has negative earnings. The Medical Imaging segment offers computed tomography (CT) detector systems, data acquisition systems, data management systems, and integrated CT systems; magnetic resonance imaging products, including gradient and radio frequency amplifiers; and digital mammography products, such as detector plates, as well as motion control devices for use in computer-controlled automation systems primarily for the semiconductor, food and beverage, and laboratory automation markets.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.